Dr. Witkin is available for appointments in Boston.

Andre J. Witkin, MD

Retinal & Macular Disease

 

Dr. Witkin is available for consultation in all areas of medical and surgical vitreoretinal diseases. His special clinical interests include: macular degeneration, macular holes and puckers, diabetic retinopathy, retinal vascular disease, central serous chorioretinopathy, retinal detachment, posterior segment uveitis, ocular trauma, complications of eye surgery, intraocular lens replacement, and implementation of retinal prosthesis (Argus II).

Dr. Witkin is the Director of Clinical Research at New England Eye Center. His particular research interests include retinal imaging, treatment of exudative and non-exudative age-related macular degeneration, treatment of central serous chorioretinopathy, toxicity and side effects of intraocular medications. Recently, he was the lead author of an article on a newly identified syndrome called Hemorrhagic Occlusive Retinal Vasculitis, or HORV.

 

Dr. Witkin's Office: 617-636-7950

Fax: 617-636-4866

Patient Appointments: 617-636-4600

 

Fellowship

Vitreoretinal Surgery, Wills Eye Institute, Philadelphia, PA
Research Fellowship, New England Eye Center

Residency

Ophthalmology, Tufts Medical Center, New England Eye Center, Boston, MA

Medical School

Weill Cornell Medical College, New York, NY

Academic Appointment

Assistant Professor of Ophthalmology, Tufts University School of Medicine

Board Certification

American Board of Ophthalmology

Research Interests

Dr. Witkin is the Director of Clinical Research at New England Eye Center.   His particular research interests include retinal imaging, treatment of exudative and non-exudative age-related macular degeneration, treatment of central serous chorioretinopathy, toxicity and side effects of intraocular medications.   Recently, he was the lead author of an article on a newly identified syndrome called Hemorrhagic Occlusive Retinal Vasculitis, or HORV.

 

Professional Honors and Awards

Honor Award, American Society of Retina Specialists, 2017
Achievement Award, American Academy of Ophthalmology, 2017

 

Personal Interests

Dr. Witkin loves spending time with his two young daughters,  and strives to have as much time with them as possible. An avid downhill skier,  he skis locally whenever he has time, and tries to go out West to ski once a year.  He is a New England Patriots fan. 


Academic Affiliations/Memberships

  • American Society of Retina Specialists (ASRS), member
  • ASRS Research in Safety and Therapeutics Committee, member
  • Retina Society, member
  • American Academy of Ophthalmology, fellow
  • Association for Research in Vision and Ophthalmology, member
  • New England Ophthalmological Society, member
  • Massachusetts Society of Eye Physicians and Surgeons, member

 

Foreign languages

French

 

Selected Publications

Book: Age-Related Macular Degeneration: Clinical Management.  Editors: Andre J. Witkin and Jay S. Duker.  Slack, Inc, Thorofare, NJ.  2014.

 

Journal Publications: Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes.
Witkin AJ, Chang DF, Jumper JM, Charles S, Eliott D, Hoffman RS, Mamalis N, Miller KM, Wykoff CC.
Ophthalmology. 2017 May;124(5):583-595.

Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment.
Witkin AJ, Rayess N, Garg SJ, Maguire JI, Storey P, Kaiser RS, Hsu J, Vander JF, Ho AC.
Semin Ophthalmol. 2017;32(3):309-315.

CORRELATION OF SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AND CLINICAL ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Liang MC, de Carlo TE, Baumal CR, Reichel E, Waheed NK, Duker JS, Witkin AJ.
Retina. 2016 Dec;36(12):2265-2273.

Visualization of the Retinal Vasculature Using Wide-Field Montage Optical Coherence Tomography Angiography.
de Carlo TE, Salz DA, Waheed NK, Baumal CR, Duker JS, Witkin AJ.
Ophthalmic Surg Lasers Imaging Retina. 2015 Jun;46(6):611-6.

Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical Spectrum and Possible Association with Vancomycin.
Witkin AJ, Shah AR, Engstrom RE, Kron-Gray MM, Baumal CR, Johnson MW, Witkin DI, Leung J, Albini TA, Moshfeghi AA, Batlle IR, Sobrin L, Eliott D.
Ophthalmology. 2015 Jul;122(7):1438-51.

A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study.
Pitcher JD 3rd, Witkin AJ, DeCroos FC, Ho AC.
Br J Ophthalmol. 2015 Jun;99(6):848-52.

Enhanced vitreous imaging in healthy eyes using swept source optical coherence tomography.
Liu JJ, Witkin AJ, Adhi M, Grulkowski I, Kraus MF, Dhalla AH, Lu CD, Hornegger J, Duker JS, Fujimoto JG.
PLoS One. 2014 Jul 18;9(7):e102950.

Vision loss after intravitreal ocriplasmin: correlation of spectral-domain optical coherence tomography and electroretinography.
Tibbetts MD, Reichel E, Witkin AJ.
JAMA Ophthalmol. 2014 Apr 1;132(4):487-90.

Comparative analysis of the retinal microvasculature visualized with fluorescein angiography and the retinal function imager.
Witkin AJ, Alshareef RA, Rezeq SS, Sampat KM, Chhablani J, Bartsch DU, Freeman WR, Haller JA, Garg SJ.
Am J Ophthalmol. 2012 Nov;154(5):901-907.e2.

 

Andre Witkin, MD